Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. announced that the FDA has accepted for review the New Drug Application (NDA)...
Charleston Laboratories, Inc., and Daiichi Sankyo, Inc., confirmed that the FDA has issued a Complete Response Letter (CRL) regarding the...